OpenAI-backed biotech firm Chai Discovery raises $130M Series B at ...
Experts suggest that chai discovery, a biotech startup with backing from openai, announced an $130 million series b round at a $1 This highlights that 3 billion valuation on monday In recent developments, the round was led by general catalyst and oak hc/ft, the company said Interestingly, other participants include menlo ventures, openai, dimension, thrive capital, neo, yosemite venture fund, lachy groom, sv angel, and new investors glade brook and emerson collective In recent developments, the firm’s total funding now stands at over $225 million In recent developments, the company is one in a growing industry that sees ai as a faster route towards drug development This highlights that in august, menlo ventures announced it was leading chai’s $70 million series a round Interestingly, the investor described chai as a startup that was building foundation models tuned for drug discovery, specifically to predict interactions between biochemical molecules so they could be reprogramed for cures
댓글 쓰기